英文别名:
3-(9,10-Dihydro-9,10-ethanoanthracen-9-yl)-N-methylpropan-1-amine;N-Methyl-9,10-ethanoanthracene-9(10H)-propanamine;Maprotiline;[14C]-Maprotiline;9-[3-(methylamino)propyl]-9,10-dihydro-9,10-ethanoanthracene;Deprilept;Dibencycladine;Maprotilin;Maprotilina;Maprotilina [INN-Spanish];Maprotilinum;Maprotilinum [INN-Latin];Maprotylina;Maprotylina [Polish];276-Ba;Ludiomil;Maprotyline;n-methyl-10-ethanoanthracene-9(10h)-propylamine;N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine;9,10-Ethanoanthracene-9(10H)-propylamine, N-methyl-;Maprotiline (base and/or unspecified salts);MAPROTILINE [USAN];NCGC00024886-02;GTPL2402;NCGC00015708-07;NCGC00015708-12;MAPROTILINE [MI];SDCCGSBI-0050789.P005;N-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine;Prestwick0_000346;SPBio_000218;2,6-dimethoxbenzoylacetonitrile;Spectrum3_000483;MAPROTILINE [MART.];IDI1_000891;NCGC00015708-25;NCGC00018217-01;BRD-K03319035-003-02-7;EN300-297414;Spectrum5_000918;NINDS_000891;BRD-K03319035-001-01-3;NCGC00015708-15;Spectrum_000887;KBio2_003935;NCGC00024886-01;N-Methyl-9,10-ethanoanthracene-9(10H)-propanamine;N-Methyl-9,10-ethanoanthracene-9(10H)-propanamine;NCGC00015708-05;AKOS005530670;Lopac0_000812;D02566;MAPROTILINE [VANDF];SBI-0050789.P003;Tocris-0935;EINECS 233-599-4;NCGC00015708-09;DTXCID5025029;CHEMBL21731;NCGC00015708-08;Tox21_110200;Prestwick3_000346;CCG-204896;9,10-Ethanoanthracene-9(10H)-propanamine, N-methyl-;Spectrum4_000035;HMS2089K11;J-000745;SCHEMBL121015;AB00514665;BPBio1_000453;NCGC00015708-17;SCHEMBL33993;10262-69-8;2U1W68TROF;SMP1_000169;BA-34276 FREE BASE;AR-111;DB00934;NCGC00015708-11;Maprotiline (USAN);KBio2_006503;NCGC00015708-13;SPBio_002332;SCHEMBL21994200;NCGC00015708-03;KBio1_000891;AB00053679_35;BSPBio_001945;NCGC00015708-06;Q418361;BDBM50378025;Dibencycladine, Deprilept, Ludiomil;NCGC00015708-10;HY-B0444A;methyl({3-[(1r)-tetracyclo[6.6.2.0^{2,7}.0^{9,14}]hexadeca-2(7),3,5,9(14),10,12-hexaen-1-yl]propyl})amine;QSLMDECMDJKHMQ-UHFFFAOYSA-N;Prestwick1_000346;BA-34,276 FREE BASE;AB01275432-01;Maprotiline [USAN:INN:BAN];Prestwick2_000346;BSPBio_000411;DTXSID7045029;KBio3_001445;Tox21_110200_1;NCGC00024886-03;AB00053679-33;KBioSS_001367;CHEBI:6690;NCGC00015708-02;CAS-10347-81-6;CHEMBL1201257;EN300-226729;DivK1c_000891;BRD-K25433859-003-14-8;AB00053679_34;Spectrum2_000139;methyl(3-{tetracyclo[6.6.2.0^{2,7}.0^{9,14}]hexadeca-2(7),3,5,9(14),10,12-hexaen-1-yl}propyl)amine;NCGC00015708-04;AC-12507;BDBM50101973;CS-0013653;L001173;BRD-K25433859-003-11-4;Lopac-M-9651;CAS-10262-69-8;C07107;PD132485;NCGC00016691-01;3-(9,10-Dihydro-9,10-ethanoanthracen-9-yl)propylmethylamine;MAPROTILINE [INN];MLS001201766;NS00009793;SMR000641863;UNII-2U1W68TROF;NCGC00015708-01;HMS2962E12;NCGC00015708-19;MAPROTILINE [WHO-DD];KBio2_001367;BA-34,276 [AS HYDROCHLORIDE];KBioGR_000469;BRN 2385493;BA-34276 [As Hydrochloride];methyl(3-(tetracyclo(6.6.2.02,7.09,14)hexadeca-2,4,6,9,11,13-hexaen-1-yl)propyl)amine;3-(9,10-ethanoanthracen-9(10H)-yl)-N-methylpropan-1-amine;Maprotilina (INN-Spanish);Ludiomil (TN);BRD-K25433859-003-24-7;DA-75318;N06AA21;G78229;methyl(3-{tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaen-1-yl}propyl)amine;STK711156;BA-34,276 (AS HYDROCHLORIDE);BRD-K25433859-003-23-9;BBL010079;methyl(3-(tetracyclo(6.6.2.0^(2,7).0^(9,14))hexadeca-2(7),3,5,9(14),10,12-hexaen-1-yl)propyl)amine;BRD-K25433859-003-25-4;Maprotilinum (INN-Latin);MAPROTILINE (MART.);